Dr. Patrick Langham Gleason, MD

Dr. Gleason practices at CHRISTUS Mother Frances Hospital - Clinic Services - Douglas - HOPD in Tyler, Texas.

Dr. Gleason's NPI, 1629030804, was assigned on April 4, 2006. Dr. Gleason graduated from Harvard Medical School in 1989. Dr. Gleason holds Texas license L6913.

Dr. Gleason's primary practice is CHRISTUS Mother Frances Hospital - Clinic Services - Douglas - HOPD, at 520 Douglas Blvd, Tyler, TX 75702.

Dr. Gleason's primary practice is CHRISTUS Mother Frances Hospital - Clinic Services - Douglas - HOPD in Tyler, Texas. Dr. Gleason is also affiliated with CHRISTUS Spohn Hospital Corpus Christi - Shoreline. The medical group on file is CHRISTUS Trinity Clinic. Dmand AI also links Dr. Gleason to 2 more group practices and clinics, 2 medical groups and 1 urgent care center, each named with a free account. Dr. Gleason's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gleason practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Gleason's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Gleason is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Gleason's licenses on file in 4 states: Texas, New Mexico, Pennsylvania and Virginia.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Gleason treats.

CMS data shows 149 Medicare services from Dr. Gleason across 4 procedure codes in 2024, for 119 Medicare patients. Medicare paid $13,086 for them.

CMS counts 119 Medicare patients who saw Dr. Gleason in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gleason's median patient age at 63, with 50% women.

In 2024, Dr. Gleason wrote 1,117 Medicare Part D claims for 230 patients. 100% of them were for generic drugs. CMS names the drug for 1,022 of them, across 12 drugs with 11 or more claims each, at $19,365 in total drug cost. In 2023, CMS named 1,121 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gleason for performance year 2024, reported individually. Dr. Gleason accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of spinal fusion by Dr. Gleason, more than 52% of the clinicians it reports for that procedure.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Gleason. The most frequent topics are Magnetic Resonance Imaging, Stereotaxic Techniques and Image Processing, Computer-Assisted. Dr. Gleason has published most often in Neurosurgery. Dr. Gleason's most frequent co-authors are Peter Mclaren Black, MD, PhD, Thomas M. Moriarty, MD, PhD and Philip Stieg, MD.

CMS Open Payments shows 170 general payments to Dr. Gleason from 48 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 49% of the total. SpineSmith Holdings, LLC paid the most, $11,103.

Dmand AI lists 1 award for Dr. Gleason, most recently Phi Beta Kappa in 1984.

Dr. Gleason graduated from Harvard Medical School in 1989. Dr. Gleason is a member of AANS, CNS and International Society for Pediatric Neurosurgery.

Dr. Gleason is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.